TABLE 2.

¹⁷⁷Lu-Pentixather Time-Integrated Activity Coefficients in Whole Body, Organs, Tumorous Lesions, Red Marrow, and Blood, as Well as Tissue-Absorbed Doses per Administered Activity in Organs and Lesions

	WB	Kidneys		Liver		Spleen		Red marrow		Lesion	Blood
Patient no.	ã (h)	ã (h)	D/A (Gy/GBq)	ã (h)	D/A (Gy/GBq)	ã (h)	D/A (Gy/GBq)	ã (h)	D/A (Gy/GBq)	D/A (Gy/GBq)	ã (h/L)
1	51.6	4.39	1.01	3.8	0.39	2.06	0.58	4.0	0.14	2.2	0.21
2	56.1	2.42	0.71	14.4	0.82	2.49	1.55	8.1	0.37	6.9	0.58
3	55.3	4.85	2.10	15.2	0.93	1.27	0.72	14.3	0.66		0.48
4	97.6	4.61	1.48	16.2	0.80	2.03	0.70	13.7	0.48		0.28
5	87.7	1.92	0.87	12.2	0.91	3.71	1.59	16.8	0.59	1.7
6	62.1	1.74	0.50	11.7	0.62	0.63	0.34	11.8	0.41	3.1
7	111.0	6.25	3.47	15.0	1.17	1.34	1.12	10.6	0.48
8	61.6	5.28	1.21	10.0	0.39	0.90	0.38	9.4	0.43
9	111.6	4.76	1.12	13.2	0.67	1.18	0.47	13.6	0.47
10	50.5	4.51	0.90	9.0	0.43	2.47	0.40	9.9	0.35		0.32
11	55.9	4.34	1.14	8.0	0.42	1.43	0.48	9.1	0.32		0.34
12	77.8	2.03	0.79	13.9	0.71	3.46	0.75	21.3	0.97	1.1
13	114.9	7.87	0.91	21.9	0.67	2.65	0.35	22.8	1.04	2.1
14	83.6	1.63	0.59	16.7	0.88	11.5	1.20	16.4	0.75
15	140.9	1.04	0.38	15.5	0.71	14.0	2.26	51.0	2.33
16	108.8	3.22	1.07	14.1	0.50	6.51	1.03	12.2	0.56	1.6	0.28
17	73.6	1.93	0.52	20.1	0.92	2.38	0.56	5.5	0.25	2.3	0.28
18	51.6	3.47	0.67	12.0	0.41	3.30	0.42	4.0	0.14	1.1	0.32
19	48.0	5.23	1.96	9.4	0.81	0.44	0.48	8.5	0.39	0.7	0.44
P	0.03	0.31	<0.01	0.95	0.21	<0.01	< 0.01	<0.01	<0.01	< 0.01	0.23
Minimum	48.0	1.04	0.38	3.7	0.39	0.44	0.34	4.0	0.14	0.7	0.21
First quartile	55.6	1.98	0.70	10.9	0.47	1.30	0.45	8.8	0.36	1.2	0.28
Median	73.6	4.34	0.91	13.9	0.71	2.38	0.58	11.8	0.47	1.9	0.32
Third quartile	103.2	4.80	1.18	15.4	0.85	3.38	1.08	15.4	0.62	2.3	0.42
Maximum	140.9	7.87	3.47	21.9	1.17	14.0	2.26	51.0	2.33	6.9	0.58
Mean	79.0	3.77	1.13	13.3	0.69	3.36	0.81	13.8	0.59	2.3	0.35
SD	27.9	1.82	0.73	4.2	0.22	3.61	0.52	10.4	0.49	1.8	0.11

WB = whole body; ã = time-integrated activity coefficient; D/A = tissue-absorbed doses per administered activity.
P values are from Shapiro–Wilk test of normality.